Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Detection of a new JCV strain of genotype A in a subpopulation of colorectal adenocarcinomas in Tunisia

Toumi W, Ripalti A, Ricciardiello L, Cherif A, Gargouri D, Bouhafa A, Kharrat J, Jarboui S, Benrhouma H, Zili M, Khelifa R.

New Microbiol. 2017 Apr;40(2):99-106. Epub 2017 Mar 3.

2.

How virus persistence can initiate the tumorigenesis process.

Avanzi S, Alvisi G, Ripalti A.

World J Virol. 2013 May 12;2(2):102-9. doi: 10.5501/wjv.v2.i2.102. Review.

3.

Regulated transport into the nucleus of herpesviridae DNA replication core proteins.

Gualtiero A, Jans DA, Camozzi D, Avanzi S, Loregian A, Ripalti A, Palù G.

Viruses. 2013 Sep 16;5(9):2210-34. doi: 10.3390/v5092210.

4.

Susceptibility of human placenta derived mesenchymal stromal/stem cells to human herpesviruses infection.

Avanzi S, Leoni V, Rotola A, Alviano F, Solimando L, Lanzoni G, Bonsi L, Di Luca D, Marchionni C, Alvisi G, Ripalti A.

PLoS One. 2013 Aug 5;8(8):e71412. doi: 10.1371/journal.pone.0071412. Print 2013.

5.

The human cytomegalovirus DNA polymerase processivity factor UL44 is modified by SUMO in a DNA-dependent manner.

Sinigalia E, Alvisi G, Segré CV, Mercorelli B, Muratore G, Winkler M, Hsiao HH, Urlaub H, Ripalti A, Chiocca S, Palù G, Loregian A.

PLoS One. 2012;7(11):e49630. doi: 10.1371/journal.pone.0049630. Epub 2012 Nov 15.

6.

Multiple phosphorylation sites at the C-terminus regulate nuclear import of HCMV DNA polymerase processivity factor ppUL44.

Alvisi G, Marin O, Pari G, Mancini M, Avanzi S, Loregian A, Jans DA, Ripalti A.

Virology. 2011 Sep 1;417(2):259-67. doi: 10.1016/j.virol.2011.06.015. Epub 2011 Jul 8.

7.

The flexible loop of the human cytomegalovirus DNA polymerase processivity factor ppUL44 is required for efficient DNA binding and replication in cells.

Alvisi G, Roth DM, Camozzi D, Pari GS, Loregian A, Ripalti A, Jans DA.

J Virol. 2009 Sep;83(18):9567-76. doi: 10.1128/JVI.00669-09. Epub 2009 Jul 1.

8.

Nuclear import of HSV-1 DNA polymerase processivity factor UL42 is mediated by a C-terminally located bipartite nuclear localization signal.

Alvisi G, Avanzi S, Musiani D, Camozzi D, Leoni V, Ly-Huynh JD, Ripalti A.

Biochemistry. 2008 Dec 30;47(52):13764-77. doi: 10.1021/bi800869y.

PMID:
19053255
9.

Role of homodimerization of human cytomegalovirus DNA polymerase accessory protein UL44 in origin-dependent DNA replication in cells.

Sinigalia E, Alvisi G, Mercorelli B, Coen DM, Pari GS, Jans DA, Ripalti A, Palù G, Loregian A.

J Virol. 2008 Dec;82(24):12574-9. doi: 10.1128/JVI.01193-08. Epub 2008 Oct 8.

10.

Regulated nucleocytoplasmic trafficking of viral gene products: a therapeutic target?

Alvisi G, Rawlinson SM, Ghildyal R, Ripalti A, Jans DA.

Biochim Biophys Acta. 2008 Jan;1784(1):213-27. Epub 2007 Aug 31. Review.

PMID:
17933596
11.
12.

Human cytomegalovirus DNA polymerase catalytic subunit pUL54 possesses independently acting nuclear localization and ppUL44 binding motifs.

Alvisi G, Ripalti A, Ngankeu A, Giannandrea M, Caraffi SG, Dias MM, Jans DA.

Traffic. 2006 Oct;7(10):1322-32. Epub 2006 Aug 15.

13.
14.
15.

Induction of chromosomal instability in colonic cells by the human polyomavirus JC virus.

Ricciardiello L, Baglioni M, Giovannini C, Pariali M, Cenacchi G, Ripalti A, Landini MP, Sawa H, Nagashima K, Frisque RJ, Goel A, Boland CR, Tognon M, Roda E, Bazzoli F.

Cancer Res. 2003 Nov 1;63(21):7256-62.

16.

[Amino acid sequence analysis of peptides that can react to the nuclear localization signals of human cytomegalovirus PPUL44].

Ruan Q, Ripalti A, Landini MP.

Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2001 Mar;15(1):69-72. Chinese.

PMID:
12526308
17.

Distinct epitopes on formiminotransferase cyclodeaminase induce autoimmune liver cytosol antibody type 1.

Muratori L, Sztul E, Muratori P, Gao Y, Ripalti A, Ponti C, Lenzi M, Landini MP, Bianchi FB.

Hepatology. 2001 Sep;34(3):494-501.

PMID:
11526534
18.

Development and clinical evaluation of a recombinant-antigen-based cytomegalovirus immunoglobulin M automated immunoassay using the Abbott AxSYM analyzer.

Maine GT, Stricker R, Schuler M, Spesard J, Brojanac S, Iriarte B, Herwig K, Gramins T, Combs B, Wise J, Simmons H, Gram T, Lonze J, Ruzicki D, Byrne B, Clifton JD, Chovan LE, Wachta D, Holas C, Wang D, Wilson T, Tomazic-Allen S, Clements MA, Wright GL Jr, Lazzarotto T, Ripalti A, Landini MP.

J Clin Microbiol. 2000 Apr;38(4):1476-81.

19.

Liver/kidney microsomal antibody type 1 targets CYP2D6 on hepatocyte plasma membrane.

Muratori L, Parola M, Ripalti A, Robino G, Muratori P, Bellomo G, Carini R, Lenzi M, Landini MP, Albano E, Bianchi FB.

Gut. 2000 Apr;46(4):553-61.

20.

Expression and characterization of a novel structural protein of human cytomegalovirus, pUL25.

Battista MC, Bergamini G, Boccuni MC, Campanini F, Ripalti A, Landini MP.

J Virol. 1999 May;73(5):3800-9.

21.

Procedure for the quantitation of Gadd45 expression levels in clonal hematopoietic progenitor cells by competitive polymerase chain reaction.

Santucci MA, Ripalti A, di Paola MC, Mianulli AM, Iacurti E, Campanini F, Gamberi B, Tura S.

Clin Biochem. 1999 Feb;32(1):1-8.

PMID:
10074885
22.

Development of a new cytomegalovirus (CMV) immunoglobulin M (IgM) immunoblot for detection of CMV-specific IgM.

Lazzarotto T, Ripalti A, Bergamini G, Battista MC, Spezzacatena P, Campanini F, Pradelli P, Varani S, Gabrielli L, Maine GT, Landini MP.

J Clin Microbiol. 1998 Nov;36(11):3337-41.

23.

The major open reading frame of the beta2.7 transcript of human cytomegalovirus: in vitro expression of a protein posttranscriptionally regulated by the 5' region.

Bergamini G, Reschke M, Battista MC, Boccuni MC, Campanini F, Ripalti A, Landini MP.

J Virol. 1998 Oct;72(10):8425-9.

24.

Human cytomegalovirus product UL44 downregulates the transactivation of HIV-1 long terminal repeat.

Boccuni MC, Campanini F, Battista MC, Bergamini G, Dal Monte P, Ripalti A, Landini MP.

AIDS. 1998 Mar 5;12(4):365-72.

PMID:
9520165
25.

Human cytomegalovirus late-phase maturation is blocked by stably expressed UL32 antisense mRNA in astrocytoma cells.

Meyer HH, Ripalti A, Landini MP, Radsak K, Kern HF, Hensel GM.

J Gen Virol. 1997 Oct;78 ( Pt 10):2621-31.

PMID:
9349484
26.

A novel Western blot test containing both viral and recombinant proteins for anticytomegalovirus immunoglobulin M detection.

Lazzarotto T, Maine GT, Dal Monte P, Ripalti A, Landini MP.

J Clin Microbiol. 1997 Feb;35(2):393-7.

27.

Intracellular production of a major cytomegalovirus antigenic protein in the methylotrophic yeast Pichia pastoris.

Battista MC, Bergamini G, Campanini F, Landini MP, Ripalti A.

Gene. 1996 Oct 17;176(1-2):197-201.

PMID:
8918253
28.

Stably expressed antisense RNA to cytomegalovirus UL83 inhibits viral replication.

Dal Monte P, Bessia C, Ripalti A, Landini MP, Topilko A, Plachter B, Virelizier JL, Michelson S.

J Virol. 1996 Apr;70(4):2086-94.

29.

Human cytomegalovirus infection: a complex diagnostic problem in which molecular biology has induced a rapid evolution.

Monte PD, Lazzarotto T, Ripalti A, Landini MP.

Intervirology. 1996;39(3):193-203. Review.

PMID:
9058172
30.

Recombinant mono- and polyantigens to detect cytomegalovirus-specific immunoglobulin M in human sera by enzyme immunoassay.

Landini MP, Lazzarotto T, Maine GT, Ripalti A, Flanders R.

J Clin Microbiol. 1995 Oct;33(10):2535-42.

32.

Construction of a polyepitope fusion antigen of human cytomegalovirus ppUL32 and detection of specific antibodies by ELISA.

Ripalti A, Boccuni MC, Campanini F, Bergamini G, Lazzarotto T, Battista MC, Dalla Casa B, Landini MP.

New Microbiol. 1995 Jan;18(1):1-12.

PMID:
7539096
33.

Construction of polyepitope fusion antigens of human cytomegalovirus ppUL32: reactivity with human antibodies.

Ripalti A, Ruan Q, Boccuni MC, Campanini F, Bergamini G, Landini MP.

J Clin Microbiol. 1994 Feb;32(2):358-63.

34.

Prokaryotic expression of a large fragment of the most antigenic cytomegalovirus DNA-binding protein (ppUL44) and its reactivity with human antibodies.

Ripalti A, Dal Monte P, Boccuni MC, Campanini F, Lazzarotto T, Campisi B, Ruan Q, Landini MP.

J Virol Methods. 1994 Jan;46(1):39-50.

PMID:
8175946
35.

Lack of correlation between virus detection and serologic tests for diagnosis of active cytomegalovirus infection in patients with AIDS.

Lazzarotto T, Dal Monte P, Boccuni MC, Ripalti A, Landini MP.

J Clin Microbiol. 1992 Apr;30(4):1027-9.

36.

Evidence that human cytomegalovirus assembly protein shares antigenic sites with an uninfected cell membrane protein.

Landini MP, Lazzarotto T, Percivalle E, Ripalti A, Gerna G.

J Gen Virol. 1991 Dec;72 ( Pt 12):3009-16.

PMID:
1722504
37.

Human cytomegalovirus structural proteins: immune reaction against pp150 synthetic peptides.

Landini MP, Ripalti A, Sra K, Pouletty P.

J Clin Microbiol. 1991 Sep;29(9):1868-72.

38.

Antigenic variation of cytomegalovirus isolates recovered from infected children.

Lazzarotto T, Boccuni MC, Dal Monte P, Ripalti A, Landini MP.

Microbiologica. 1991 Jul;14(3):241-51.

PMID:
1656167
39.

Large-scale screening of human sera with cytomegalovirus recombinant antigens.

Landini MP, Guan MX, Jahn G, Lindenmaier W, Mach M, Ripalti A, Necker A, Lazzarotto T, Plachter B.

J Clin Microbiol. 1990 Jun;28(6):1375-9.

40.

A simple and rapid procedure for the direct detection of cytomegalovirus in urine samples.

Landini MP, Trevisani B, Guan MX, Ripalti A, Lazzarotto T, La Placa M.

J Clin Lab Anal. 1990;4(3):161-4.

PMID:
2161915
41.

Relationship between human immunodeficiency virus antigenemia and cytomegalovirus infection.

Lazzarotto T, Guan MX, Furlini G, Re MC, Ripalti A, Landini MP, La Placa M.

Microbiologica. 1990 Jan;13(1):61-5.

PMID:
2155377
42.

Antibody response to recombinant lambda gt11 fusion proteins in cytomegalovirus infection.

Landini MP, Lazzarotto T, Ripalti A, Guan MX, La Placa M.

J Clin Microbiol. 1989 Oct;27(10):2324-7.

43.

Identification and preliminary use of recombinant lambda gt11 fusion proteins in human cytomegalovirus diagnosis.

Ripalti A, Landini MP, Mocarski ES, La Placa M.

J Gen Virol. 1989 May;70 ( Pt 5):1247-51.

PMID:
2543778
44.

Antibody reactivity to cytomegalovirus structural polypeptides in subclinical and clinical human immunodeficiency virus infections.

Landini MP, Mirolo G, Re MC, Ripalti A, La Placa M.

Eur J Clin Microbiol Infect Dis. 1989 Feb;8(2):159-63.

PMID:
2542032
45.

Diagnostic avail of a biotinylated DNA probe made from the XbaI E fragment of human cytomegalovirus genome.

Ripalti A, Trevisani B, Landini MP, La Placa M.

Microbiologica. 1989 Jan;12(1):1-6.

PMID:
2541316
46.

Human cytomegalovirus-associated DNase and the specific immune response in different clinical conditions.

Ripalti A, Landini MP.

Biochem Pharmacol. 1988 May 1;37(9):1873-4. No abstract available.

PMID:
2837245
47.

Reactivity of cytomegalovirus structural polypeptides with different subclasses of IgG present in human serum.

Landini MP, Baldassarri B, Mirolo G, Ripalti A, La Placa M.

J Infect. 1988 Mar;16(2):163-7.

PMID:
2832481
49.

Antibody response to individual cytomegalovirus structural proteins in different groups of subjects.

Mirolo G, Baldassarri B, Ripalti A, Re MC, Clementi M, Manzin A, Landini MP.

Eur J Clin Microbiol. 1987 Apr;6(2):207-10.

PMID:
3036503
50.

[Possible inhibitors of experimental viral replication against cytomegalovirus. Results and prospectives].

Landini MP, Baldassarri B, Ripalti A.

G Ital Chemioter. 1985 Jan-Apr;32(1):119-26. Italian. No abstract available.

PMID:
3007252

Supplemental Content

Loading ...
Support Center